Since 2017, Mainland China has greatly expanded availability of novel drugs through regulatory reforms, bringing greater access from domestic and international manufacturers alike. Read our latest blog here: ow.ly/QbsT50OtujO #oncology #rarediseases #pharma #MainlandChina

Looking forward to what looks like a very cool event in London on 21st June - the World Without Disease Summit - stellar speaker line up worldwithoutdisease.com

Exciting news! Join us at #BIO2023 by Biotechnology Innovation Organization for an insightful panel on #biotech partnerships in #oncology, moderated by Mike Ward. Plus, explore our innovative solutions at Booth #1965: ow.ly/vBvY50OvcVL

Life science research has accelerated over the past few decades, especially with challenge of #COVID. Clarivate experts Jonathan Adams and David Pendlebury from the #ISI discuss how scientific #research is evolving in the US. Listen at ow.ly/ECJc50OAUxX. #pharma #biotech

Heading off to Boston for Biotechnology Innovation Organization BBIO2023. Looking forward to chairing an insightful panel on #biotech partnerships in #oncology, with execs from Pfizer Inc., Shigeru Takeda & Volastra Therapeutics. Also explore Clarivate for Life Sciences & Healthcare innovative solutions at Booth #1965: ow.ly/vBvY50OvcVL

Coming up on June 15, a webinar hosted by Mike Ward of Clarivate will feature ACMA CEO William Soliman, Ph.D., for a conversation on the impact of biologics and biosimilars on the US Market. Register here: hubs.ly/Q01SvnBT0

BioWorld brings together leaders of preclinical companies for hot topics discussion at #BIO2023 @DTxPharma Combined Therapeutics Kytopen Lynn Yoffee Elevation Oncology Mike Ward Russo Partners

We had a very enlightening conversation — much food for thought and #pharma #biotech

I have 3 new followers from Azerbaijan, and more last week. See fedica.com/!BioPharmaMike

The World Health Organization (WHO) global research agenda for antimicrobial resistance #AMR in human health prioritizes 40 R&D topics to generate new evidence to inform AMR policies and interventions by 2030. Available here: lnkd.in/ej9tNbXh. #WHO #AMRResearchAgenda #Launch

Pleased to take part in latest episode of the #BioWorld Insider Podcast, alongside BioWorld managing editor Karen Carey to talk about #biopharma deal making, M&A and financing trends in 1H 2023 plus how U.K. firms faring post #Brexit Download from here: lnkd.in/gMGeJHdT

Special thank you to my 4 new followers from South Africa, and more last week. fedica.com/!BioPharmaMike

Excited to share, this year’s Clarivate Drugs to Watch report is the winner ow.ly/8Xg550PIXIA of TWO 2023 #DataComms Awards -- GOLD in the Best Data Insight from an Integrated Campaign category and BRONZE in the Most Innovative Use of Data category!

Will be moderating a panel discussion at One Nucleus #Genesis conference looking at the anatomy of a star #biopharma #dealmaker. Interested in hearing from here what are the key attributes required? #biotech #pharma

I have 2 new followers from Iceland, and more last week. See fedica.com/!BioPharmaMike

The 2023 #Nobel Prize in Physiology or Medicine has been awarded to Katalin Kariko and Drew Weissman, the scientists that developed the technology that led to the #mRNA #Covid vaccines. #biotech #pharma

The world has gone mad - how can anyone celebrate the massacre of innocents?

First #USFDA NDA submission for any psychedelic-assisted therapy as MAPS PBC seeks approval for an #MDMA-assisted therapy for #PTSD; #NDA includes two Phase 3 trials (MAPP1 and MAPP2) that both met primary and secondary endpoints #pharma #biotech

Just to let my followers here know, like many others, I will be transitioning to Blue Sky - my handle will be Mike Ward.bsky.social #biotech #biopharma #medtech

Working on my annual #biopharma and #medtech “Winners & Losers” presentation for the Genesis 2024 conference. Happy to receive nominations for entry into the list - list them here or send to [email protected]